Quantbot Technologies LP Sells 4,057 Shares of iShares Biotechnology ETF $IBB

Quantbot Technologies LP cut its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 39.5% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 6,203 shares of the financial services provider’s stock after selling 4,057 shares during the quarter. Quantbot Technologies LP’s holdings in iShares Biotechnology ETF were worth $896,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Citigroup Inc. grew its holdings in iShares Biotechnology ETF by 27.0% during the 2nd quarter. Citigroup Inc. now owns 4,073,967 shares of the financial services provider’s stock worth $515,398,000 after acquiring an additional 865,823 shares during the last quarter. JPMorgan Chase & Co. raised its stake in shares of iShares Biotechnology ETF by 74.2% in the second quarter. JPMorgan Chase & Co. now owns 833,196 shares of the financial services provider’s stock worth $105,408,000 after acquiring an additional 355,000 shares during the last quarter. Employees Retirement System of Texas acquired a new position in shares of iShares Biotechnology ETF during the second quarter worth approximately $25,049,000. Millennium Management LLC lifted its position in shares of iShares Biotechnology ETF by 140.8% during the first quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock worth $5,330,000 after purchasing an additional 143,893 shares in the last quarter. Finally, Florin Court Capital LLP bought a new stake in shares of iShares Biotechnology ETF during the third quarter valued at approximately $11,116,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Price Performance

Shares of iShares Biotechnology ETF stock opened at $167.56 on Friday. The firm has a 50 day simple moving average of $172.68 and a 200 day simple moving average of $161.31. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $179.64.

iShares Biotechnology ETF Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 19th. Shareholders of record on Tuesday, December 16th were given a $0.1831 dividend. This represents a $0.73 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date was Tuesday, December 16th. This is a positive change from iShares Biotechnology ETF’s previous quarterly dividend of $0.08.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.